See All Slides - tctmd.com

Slides

Presentation SOLACI 2013

Deal With My Worst Complications: Case III

Presenter: Jos? A. Condado R.

July 25, 2013

Presentation SOLACI 2013

Registro Venezolano de Denervación Renal Guiada por Catéter para el Control de la Hipertensión Arterial Resistente

Presenter: Humberto Casal Pati?o

July 25, 2013

Presentation SOLACI 2013

Physiological Grounds For Invasive Indices: What is Different in the Coronary Circulation?

Presenter: Ricardo Petraco

July 25, 2013

Presentation SOLACI 2013

A Comparison of Radiation Dosage Between Three-Dimensional Rotational Angiography and Standard Two-Dimensional Acquisition: Lessons Learned and First Impressions

Presenter: Jo?o Luiz Langer Manica

July 25, 2013

Presentation SOLACI 2013

Does Thrombus Aspiration in Real World Reduces Mortality in STEMI?

Presenter: Marco V. Wainstein

July 25, 2013

Presentation SOLACI 2013

Evolução da Terapêutica Anticoagulante na SCA: Uma Nova Era

Presenter: Ot?vio Rizzi Coelho

July 25, 2013

Presentation SOLACI 2013

When is a Device Ready for a FIH Study?

Presenter: Juan F. Granada

July 24, 2013

Presentation SOLACI 2013

Current Status of Percutaneous Intervention in Mitral Insufficiency

Presenter: J. Ribamar Costa Jr.

July 24, 2013

Presentation SOLACI 2013

Why Has FFR Been Considered the Default Strategy to Guide PCI?

Presenter: Daniel Chami?

July 24, 2013

Presentation SOLACI 2013

Translational Research: Experimental Insights of Device Development

Presenter: Pedro A. Lemos

July 24, 2013

Advertisement

Slides

Deal With My Worst Complications: Case III

Registro Venezolano de Denervación Renal Guiada por Catéter para el Control de la Hipertensión Arterial Resistente

Physiological Grounds For Invasive Indices: What is Different in the Coronary Circulation?

A Comparison of Radiation Dosage Between Three-Dimensional Rotational Angiography and Standard Two-Dimensional Acquisition: Lessons Learned and First Impressions

Does Thrombus Aspiration in Real World Reduces Mortality in STEMI?

Evolução da Terapêutica Anticoagulante na SCA: Uma Nova Era

When is a Device Ready for a FIH Study?

Current Status of Percutaneous Intervention in Mitral Insufficiency

Why Has FFR Been Considered the Default Strategy to Guide PCI?

Translational Research: Experimental Insights of Device Development

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content